These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


109 related items for PubMed ID: 3983907

  • 1. Hirudin insensitive thrombin-stimulated platelet release.
    Reinhold DS, Gershman H.
    Thromb Res; 1985 Feb 15; 37(4):513-27. PubMed ID: 3983907
    [Abstract] [Full Text] [Related]

  • 2. Inhibition of the thrombin-platelet reaction by hirudin.
    Hoffmann A, Markwardt F.
    Haemostasis; 1984 Feb 15; 14(2):164-9. PubMed ID: 6735274
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Qualitative description of factors involved in the retraction and lysis of dilute whole blood clots and in the aggregation and retraction of platelets.
    Taylor FB, Müller-Eberhard HJ.
    J Clin Invest; 1970 Nov 15; 49(11):2068-85. PubMed ID: 4248913
    [Abstract] [Full Text] [Related]

  • 5. Analysis of the fate of platelet-bound thrombin.
    Yeo KT, Detwiler TC.
    Arch Biochem Biophys; 1985 Jan 15; 236(1):399-410. PubMed ID: 3917649
    [Abstract] [Full Text] [Related]

  • 6. Effect of the hirudin carboxy-terminal peptide 54-65 on the interaction of thrombin with platelets.
    Jandrot-Perrus M, Huisse MG, Krstenansky JL, Bezeaud A, Guillin MC.
    Thromb Haemost; 1991 Sep 02; 66(3):300-5. PubMed ID: 1746000
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Effect of recombinant hirudin on cytosolic Ca2+ concentrations using different platelet stimulators.
    Kirchmaier CM, Bellinger OK, Schulz B, Breddin HK.
    Haemostasis; 1991 Sep 02; 21 Suppl 1():121-6. PubMed ID: 1894187
    [Abstract] [Full Text] [Related]

  • 9. Dissociation of thrombin from platelets by hirudin. Evidence for receptor processing.
    Tam SW, Fenton JW, Detwiler TC.
    J Biol Chem; 1979 Sep 25; 254(18):8723-5. PubMed ID: 479150
    [Abstract] [Full Text] [Related]

  • 10. Effect of thrombin inhibitors on platelet functions: comparative analysis of DuP 714 and hirudin.
    Reilly TM, Knabb RM, Hassell SM, Bozarth JM, Forsythe MS, Mayo MC, Racanelli AL, Mousa SA.
    Blood Coagul Fibrinolysis; 1992 Oct 25; 3(5):513-7. PubMed ID: 1450317
    [Abstract] [Full Text] [Related]

  • 11. Antithrombin effects of native and recombinant hirudins.
    Markwardt F, Stürzebecher J, Glusa E.
    Biomed Biochim Acta; 1990 Oct 25; 49(5):399-404. PubMed ID: 2271010
    [Abstract] [Full Text] [Related]

  • 12. Platelet functions in recombinant hirudin-anticoagulated blood.
    Glusa E, Markwardt F.
    Haemostasis; 1990 Oct 25; 20(2):112-8. PubMed ID: 2363746
    [Abstract] [Full Text] [Related]

  • 13. Platelet activation in haemostasis: role of thrombin and other clotting factors in platelet-collagen interaction.
    Huzoor-Akbar, Ardlie NG.
    Haemostasis; 1977 Oct 25; 6(1):59-71. PubMed ID: 870398
    [Abstract] [Full Text] [Related]

  • 14. Requirement for thrombin receptor occupancy during platelet secretion under aggregating and non-aggregating conditions.
    Koike K, Holmsen H.
    Thromb Haemost; 1987 Dec 18; 58(4):1053-9. PubMed ID: 2832963
    [Abstract] [Full Text] [Related]

  • 15. Maintenance of patency after thrombolysis in stenotic coronary arteries requires combined inhibition of thrombin and platelets.
    Prager NA, Torr-Brown SR, Sobel BE, Abendschein DR.
    J Am Coll Cardiol; 1993 Jul 18; 22(1):296-301. PubMed ID: 8509554
    [Abstract] [Full Text] [Related]

  • 16. [Thrombin-stimulated release of serotonin from blood platelets].
    Hoffmann A, Markwardt F.
    Biomed Biochim Acta; 1984 Jul 18; 43(3):321-36. PubMed ID: 6743305
    [Abstract] [Full Text] [Related]

  • 17. A novel hirudin derivative characterized with anti-platelet aggregations and thrombin inhibition.
    Mo W, Zhang YL, Chen HS, Wang LS, Song HY.
    J Thromb Thrombolysis; 2009 Aug 18; 28(2):230-7. PubMed ID: 18998199
    [Abstract] [Full Text] [Related]

  • 18. Thrombin-receptor agonist peptides, in contrast to thrombin itself, are not full agonists for activation and signal transduction in human platelets in the absence of platelet-derived secondary mediators.
    Lau LF, Pumiglia K, Côté YP, Feinstein MB.
    Biochem J; 1994 Oct 15; 303 ( Pt 2)(Pt 2):391-400. PubMed ID: 7526841
    [Abstract] [Full Text] [Related]

  • 19. The thrombin inhibitors hirudin and Refludan(®) activate the soluble guanylyl cyclase and the cGMP pathway in washed human platelets.
    Kobsar A, Koessler J, Kehrer L, Gambaryan S, Walter U.
    Thromb Haemost; 2012 Mar 15; 107(3):521-9. PubMed ID: 22234363
    [Abstract] [Full Text] [Related]

  • 20. Factors responsible for ADP-induced release reaction of human platelets.
    Mustard JF, Perry DW, Kinlough-Rathbone RL, Packham MA.
    Am J Physiol; 1975 Jun 15; 228(6):1757-65. PubMed ID: 50744
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.